|
|
Volumn 12, Issue 5, 2012, Pages 519-521
|
|
Stemming the tide?: Advances in antibiotic discovery and development in the face of emerging resistance and financial constraint
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
CEPHALOSPORIN;
IMIPENEM;
LANTIBIOTIC;
PENICILLIN G;
PEPTIDE;
PEPTIDOMIMETIC AGENT;
POLYPEPTIDE ANTIBIOTIC AGENT;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
CHINA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MONITORING;
DRUG USE;
FINANCE;
GRAM NEGATIVE INFECTION;
HEALTH CARE COST;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
LAW;
MEDICAL PROFESSION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION;
ORGANIZATION;
PRIORITY JOURNAL;
PRODUCTIVITY;
REVIEW;
UNITED STATES;
|
|
EID: 84867330872
PISSN: 14714892
EISSN: 14714973
Source Type: Journal
DOI: 10.1016/j.coph.2012.07.018 Document Type: Editorial |
|
Times cited : (2)
|
|
References (7)
|
